Management of Antithrombin Market - Global Forecast 2025-2030

Antithrombin management is undergoing significant change, propelled by rapid advancements in biologic therapies, evolving regulatory standards, and heightened demand for tailored patient care. Senior decision-makers are prioritizing optimized strategies to secure supply, enhance treatment outcomes, and address emergent challenges in this dynamic market.

Antithrombin Market Snapshot

The global antithrombin market demonstrates steady growth, with a robust CAGR and rising demand across hospital, ambulatory, and specialty clinic settings. Market expansion is shaped by the adoption of recombinant technologies, the introduction of sophisticated monitoring solutions, and stricter regulatory oversight. Shifting trade environments and variable reimbursement models influence cost structures and strategic planning. Innovations in patient-centric platforms and supply chain management are expected to redefine delivery and competitive positioning as the sector approaches 2025.

Scope & Segmentation of the Antithrombin Market

This report delivers a comprehensive segmentation and coverage of the antithrombin landscape, outlining key technologies, end users, applications, and geographies. Strategic segmentation enables tailored insights for stakeholders across the life sciences value chain.

Route of Administration: Intravenous and Subcutaneous administration pathways, influencing clinical protocol selection and training needs.
Formulation: Liquid and Lyophilized Powder forms, selected according to shelf stability, logistics, and regional cold chain capabilities.
End User: Ambulatory Centers, Hospitals, and Specialty Clinics, each driving unique workflow and patient care requirements.
Distribution Channel: Hospital Pharmacy, Online Pharmacy, Retail Pharmacy, reflecting diverse delivery and access preferences.
Product Type: Plasma Derived and Recombinant offerings, aligned with scale, biosafety, and innovation trends.
Application: Diagnostic, Prevention, and Treatment contexts, underpinning protocol design and resource allocation.
Regions Covered: Americas (with focus states and countries), Europe, Middle East & Africa (broad multi-country coverage), Asia-Pacific (including key medical markets and emerging economies).
Leading Companies: Strategic profiling includes CSL Limited, Grifols S.A., Octapharma AG, Kedrion Biopharma S.p.A., LFB Group, Baxter International Inc., Biotest AG, Sanquin Blood Supply Foundation, Green Cross Corporation, and Bio Products Laboratory Ltd.

Key Takeaways for Decision-Makers

Emergence of recombinant antithrombin supports scaling production and reduces immunogenicity risks, enabling access for broader patient populations.
Patient-centric care models—integrating digital monitoring and real-time dosing tools—enhance personalization and adherence for chronic and acute management.
Regulatory intensification has heightened requirements for process validation and post-marketing surveillance, impacting compliance and market access strategies.
Geographic diversification in manufacturing and distribution is promoted by both risk mitigation needs and evolving regional procurement practices.
Consortium-based R&D is expanding antithrombin’s clinical indications, amplifying commercial and therapeutic opportunities.

Tariff Impact: Navigating U.S. Trade Policy Shifts

Revised U.S. tariffs are reshaping antithrombin supply chains and cost structures. The introduction of new duties on raw materials and finished therapies has affected production planning and spurred alternative sourcing strategies. Smaller producers are experiencing cost volatility, while healthcare providers and payers are adjusting reimbursement and delivery models to manage unpredictability. Long-term supply agreements and nearshoring are being adopted to ensure continuous patient access and operational resilience.

Antithrombin Market Methodology & Data Sources

This report applies a mixed-methods methodology, combining quantitative analysis from peer-reviewed clinical trials, regulatory filings, and financial disclosures with qualitative insights from expert interviews. Industry literature, events, and patent reviews supplement primary research, ensuring a robust perspective. Data triangulation and expert validation underpin trend accuracy and strategic implications for antithrombin management.

Why This Report Matters

Provides actionable guidance to optimize antithrombin supply chain performance and mitigate geopolitical or tariff-driven risks.
Identifies strategic pathways for leveraging digital health and recombinant technology integration to advance personalized patient management.
Equips leadership with a clear roadmap to navigate evolving regulatory, reimbursement, and regional market requirements.

Conclusion: Integrated Strategies for Future-Ready Antithrombin Management

The antithrombin market demands agile, evidence-driven strategies that balance regulatory mandates, regional dynamics, and clinical precision. Decision-makers positioned with holistic insights will be better equipped to drive sustainable growth and optimize patient care outcomes.

This product will be delivered within 1-3 business days.

1. Preface

1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders

2. Research Methodology

2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

4.1. Introduction
4.2. Market Sizing & Forecasting

5. Market Dynamics

5.1. Integration of point-of-care antithrombin monitoring devices in critical care protocols
5.2. Impact of novel gene therapy approaches on antithrombin deficiency management in hemophilia patients
5.3. Expansion of recombinant antithrombin supply through plant-based expression systems improving access
5.4. Adoption of AI-driven dosing algorithms for personalized antithrombin therapy in surgical settings
5.5. Rising investment in synthetic antithrombin analogs targeting unique thrombin-binding conformations
5.6. Regulatory acceleration of biosimilar antithrombin products in emerging Asian markets
5.7. Development of dual-action antithrombin formulations combining anticoagulant and anti-inflammatory properties
5.8. Cost-benefit analysis of home-based antithrombin infusion programs reducing hospital stays
5.9. Strategic partnerships between biopharma and diagnostics firms to enhance antithrombin assay accuracy
5.10. Clinical trial outcomes of long-acting antithrombin Fc-fusion protein candidates for prophylaxis

6. Market Insights

6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis

7. Cumulative Impact of United States Tariffs 2025

8. Management of Antithrombin Market, by Route Of Administration

8.1. Introduction
8.2. Intravenous
8.3. Subcutaneous

9. Management of Antithrombin Market, by Formulation

9.1. Introduction
9.2. Liquid
9.3. Lyophilized Powder

10. Management of Antithrombin Market, by End User

10.1. Introduction
10.2. Ambulatory Centers
10.3. Hospitals
10.4. Specialty Clinics

11. Management of Antithrombin Market, by Distribution Channel

11.1. Introduction
11.2. Hospital Pharmacy
11.3. Online Pharmacy
11.4. Retail Pharmacy

12. Management of Antithrombin Market, by Product Type

12.1. Introduction
12.2. Plasma Derived
12.3. Recombinant

13. Management of Antithrombin Market, by Application

13.1. Introduction
13.2. Diagnostic
13.3. Prevention
13.4. Treatment

14. Americas Management of Antithrombin Market

14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. Argentina

15. Europe, Middle East & Africa Management of Antithrombin Market

15.1. Introduction
15.2. United Kingdom
15.3. Germany
15.4. France
15.5. Russia
15.6. Italy
15.7. Spain
15.8. United Arab Emirates
15.9. Saudi Arabia
15.10. South Africa
15.11. Denmark
15.12. Netherlands
15.13. Qatar
15.14. Finland
15.15. Sweden
15.16. Nigeria
15.17. Egypt
15.18. Turkey
15.19. Israel
15.20. Norway
15.21. Poland
15.22. Switzerland

16. Asia-Pacific Management of Antithrombin Market

16.1. Introduction
16.2. China
16.3. India
16.4. Japan
16.5. Australia
16.6. South Korea
16.7. Indonesia
16.8. Thailand
16.9. Philippines
16.10. Malaysia
16.11. Singapore
16.12. Vietnam
16.13. Taiwan

17. Competitive Landscape

17.1. Market Share Analysis, 2024
17.2. FPNV Positioning Matrix, 2024
17.3. Competitive Analysis
17.3.1. CSL Limited
17.3.2. Grifols, S.A.
17.3.3. Octapharma AG
17.3.4. Kedrion Biopharma S.p.A.
17.3.5. LFB Group
17.3.6. Baxter International Inc.
17.3.7. Biotest AG
17.3.8. Sanquin Blood Supply Foundation
17.3.9. Green Cross Corporation
17.3.10. Bio Products Laboratory Ltd

18. Research AI19. Research Statistics20. Research Contacts21. Research Articles22. Appendix

List of Figures

FIGURE 1. MANAGEMENT OF ANTITHROMBIN MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL MANAGEMENT OF ANTITHROMBIN MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL MANAGEMENT OF ANTITHROMBIN MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL MANAGEMENT OF ANTITHROMBIN MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL MANAGEMENT OF ANTITHROMBIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2030 (%)
FIGURE 6. GLOBAL MANAGEMENT OF ANTITHROMBIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL MANAGEMENT OF ANTITHROMBIN MARKET SIZE, BY FORMULATION, 2024 VS 2030 (%)
FIGURE 8. GLOBAL MANAGEMENT OF ANTITHROMBIN MARKET SIZE, BY FORMULATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL MANAGEMENT OF ANTITHROMBIN MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 10. GLOBAL MANAGEMENT OF ANTITHROMBIN MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL MANAGEMENT OF ANTITHROMBIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 12. GLOBAL MANAGEMENT OF ANTITHROMBIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL MANAGEMENT OF ANTITHROMBIN MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 14. GLOBAL MANAGEMENT OF ANTITHROMBIN MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL MANAGEMENT OF ANTITHROMBIN MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 16. GLOBAL MANAGEMENT OF ANTITHROMBIN MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS MANAGEMENT OF ANTITHROMBIN MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. AMERICAS MANAGEMENT OF ANTITHROMBIN MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES MANAGEMENT OF ANTITHROMBIN MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 20. UNITED STATES MANAGEMENT OF ANTITHROMBIN MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA MANAGEMENT OF ANTITHROMBIN MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA MANAGEMENT OF ANTITHROMBIN MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ASIA-PACIFIC MANAGEMENT OF ANTITHROMBIN MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. ASIA-PACIFIC MANAGEMENT OF ANTITHROMBIN MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. MANAGEMENT OF ANTITHROMBIN MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 26. MANAGEMENT OF ANTITHROMBIN MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 27. MANAGEMENT OF ANTITHROMBIN MARKET: RESEARCHAI
FIGURE 28. MANAGEMENT OF ANTITHROMBIN MARKET: RESEARCHSTATISTICS
FIGURE 29. MANAGEMENT OF ANTITHROMBIN MARKET: RESEARCHCONTACTS
FIGURE 30. MANAGEMENT OF ANTITHROMBIN MARKET: RESEARCHARTICLES

List of Tables

TABLE 1. MANAGEMENT OF ANTITHROMBIN MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL MANAGEMENT OF ANTITHROMBIN MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL MANAGEMENT OF ANTITHROMBIN MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL MANAGEMENT OF ANTITHROMBIN MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL MANAGEMENT OF ANTITHROMBIN MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL MANAGEMENT OF ANTITHROMBIN MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL MANAGEMENT OF ANTITHROMBIN MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL MANAGEMENT OF ANTITHROMBIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL MANAGEMENT OF ANTITHROMBIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL MANAGEMENT OF ANTITHROMBIN MARKET SIZE, BY INTRAVENOUS, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL MANAGEMENT OF ANTITHROMBIN MARKET SIZE, BY INTRAVENOUS, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL MANAGEMENT OF ANTITHROMBIN MARKET SIZE, BY SUBCUTANEOUS, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL MANAGEMENT OF ANTITHROMBIN MARKET SIZE, BY SUBCUTANEOUS, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL MANAGEMENT OF ANTITHROMBIN MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL MANAGEMENT OF ANTITHROMBIN MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL MANAGEMENT OF ANTITHROMBIN MARKET SIZE, BY LIQUID, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL MANAGEMENT OF ANTITHROMBIN MARKET SIZE, BY LIQUID, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL MANAGEMENT OF ANTITHROMBIN MARKET SIZE, BY LYOPHILIZED POWDER, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL MANAGEMENT OF ANTITHROMBIN MARKET SIZE, BY LYOPHILIZED POWDER, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL MANAGEMENT OF ANTITHROMBIN MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL MANAGEMENT OF ANTITHROMBIN MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL MANAGEMENT OF ANTITHROMBIN MARKET SIZE, BY AMBULATORY CENTERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL MANAGEMENT OF ANTITHROMBIN MARKET SIZE, BY AMBULATORY CENTERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL MANAGEMENT OF ANTITHROMBIN MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL MANAGEMENT OF ANTITHROMBIN MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL MANAGEMENT OF ANTITHROMBIN MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL MANAGEMENT OF ANTITHROMBIN MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL MANAGEMENT OF ANTITHROMBIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL MANAGEMENT OF ANTITHROMBIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL MANAGEMENT OF ANTITHROMBIN MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL MANAGEMENT OF ANTITHROMBIN MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL MANAGEMENT OF ANTITHROMBIN MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL MANAGEMENT OF ANTITHROMBIN MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL MANAGEMENT OF ANTITHROMBIN MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL MANAGEMENT OF ANTITHROMBIN MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL MANAGEMENT OF ANTITHROMBIN MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL MANAGEMENT OF ANTITHROMBIN MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL MANAGEMENT OF ANTITHROMBIN MARKET SIZE, BY PLASMA DERIVED, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL MANAGEMENT OF ANTITHROMBIN MARKET SIZE, BY PLASMA DERIVED, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL MANAGEMENT OF ANTITHROMBIN MARKET SIZE, BY RECOMBINANT, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL MANAGEMENT OF ANTITHROMBIN MARKET SIZE, BY RECOMBINANT, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL MANAGEMENT OF ANTITHROMBIN MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL MANAGEMENT OF ANTITHROMBIN MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL MANAGEMENT OF ANTITHROMBIN MARKET SIZE, BY DIAGNOSTIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL MANAGEMENT OF ANTITHROMBIN MARKET SIZE, BY DIAGNOSTIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL MANAGEMENT OF ANTITHROMBIN MARKET SIZE, BY PREVENTION, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL MANAGEMENT OF ANTITHROMBIN MARKET SIZE, BY PREVENTION, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL MANAGEMENT OF ANTITHROMBIN MARKET SIZE, BY TREATMENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL MANAGEMENT OF ANTITHROMBIN MARKET SIZE, BY TREATMENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. AMERICAS MANAGEMENT OF ANTITHROMBIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 52. AMERICAS MANAGEMENT OF ANTITHROMBIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 53. AMERICAS MANAGEMENT OF ANTITHROMBIN MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 54. AMERICAS MANAGEMENT OF ANTITHROMBIN MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 55. AMERICAS MANAGEMENT OF ANTITHROMBIN MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 56. AMERICAS MANAGEMENT OF ANTITHROMBIN MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 57. AMERICAS MANAGEMENT OF ANTITHROMBIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 58. AMERICAS MANAGEMENT OF ANTITHROMBIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 59. AMERICAS MANAGEMENT OF ANTITHROMBIN MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 60. AMERICAS MANAGEMENT OF ANTITHROMBIN MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 61. AMERICAS MANAGEMENT OF ANTITHROMBIN MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 62. AMERICAS MANAGEMENT OF ANTITHROMBIN MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 63. AMERICAS MANAGEMENT OF ANTITHROMBIN MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 64. AMERICAS MANAGEMENT OF ANTITHROMBIN MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 65. UNITED STATES MANAGEMENT OF ANTITHROMBIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 66. UNITED STATES MANAGEMENT OF ANTITHROMBIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 67. UNITED STATES MANAGEMENT OF ANTITHROMBIN MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 68. UNITED STATES MANAGEMENT OF ANTITHROMBIN MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 69. UNITED STATES MANAGEMENT OF ANTITHROMBIN MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 70. UNITED STATES MANAGEMENT OF ANTITHROMBIN MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 71. UNITED STATES MANAGEMENT OF ANTITHROMBIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 72. UNITED STATES MANAGEMENT OF ANTITHROMBIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 73. UNITED STATES MANAGEMENT OF ANTITHROMBIN MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 74. UNITED STATES MANAGEMENT OF ANTITHROMBIN MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 75. UNITED STATES MANAGEMENT OF ANTITHROMBIN MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 76. UNITED STATES MANAGEMENT OF ANTITHROMBIN MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 77. UNITED STATES MANAGEMENT OF ANTITHROMBIN MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 78. UNITED STATES MANAGEMENT OF ANTITHROMBIN MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 79. CANADA MANAGEMENT OF ANTITHROMBIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 80. CANADA MANAGEMENT OF ANTITHROMBIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 81. CANADA MANAGEMENT OF ANTITHROMBIN MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 82. CANADA MANAGEMENT OF ANTITHROMBIN MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 83. CANADA MANAGEMENT OF ANTITHROMBIN MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 84. CANADA MANAGEMENT OF ANTITHROMBIN MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 85. CANADA MANAGEMENT OF ANTITHROMBIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 86. CANADA MANAGEMENT OF ANTITHROMBIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 87. CANADA MANAGEMENT OF ANTITHROMBIN MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 88. CANADA MANAGEMENT OF ANTITHROMBIN MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 89. CANADA MANAGEMENT OF ANTITHROMBIN MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 90. CANADA MANAGEMENT OF ANTITHROMBIN MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 91. MEXICO MANAGEMENT OF ANTITHROMBIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 92. MEXICO MANAGEMENT OF ANTITHROMBIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 93. MEXICO MANAGEMENT OF ANTITHROMBIN MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 94. MEXICO MANAGEMENT OF ANTITHROMBIN MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 95. MEXICO MANAGEMENT OF ANTITHROMBIN MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 96. MEXICO MANAGEMENT OF ANTITHROMBIN MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 97. MEXICO MANAGEMENT OF ANTITHROMBIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 98. MEXICO MANAGEMENT OF ANTITHROMBIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 99. MEXICO MANAGEMENT OF ANTITHROMBIN MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 100. MEXICO MANAGEMENT OF ANTITHROMBIN MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 101. MEXICO MANAGEMENT OF ANTITHROMBIN MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 102. MEXICO MANAGEMENT OF ANTITHROMBIN MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 103. BRAZIL MANAGEMENT OF ANTITHROMBIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 104. BRAZIL MANAGEMENT OF ANTITHROMBIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 105. BRAZIL MANAGEMENT OF ANTITHROMBIN MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 106. BRAZIL MANAGEMENT OF ANTITHROMBIN MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 107. BRAZIL MANAGEMENT OF ANTITHROMBIN MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 108. BRAZIL MANAGEMENT OF ANTITHROMBIN MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 109. BRAZIL MANAGEMENT OF ANTITHROMBIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 110. BRAZIL MANAGEMENT OF ANTITHROMBIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 111. BRAZIL MANAGEMENT OF ANTITHROMBIN MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 112. BRAZIL MANAGEMENT OF ANTITHROMBIN MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 113. BRAZIL MANAGEMENT OF ANTITHROMBIN MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 114. BRAZIL MANAGEMENT OF ANTITHROMBIN MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 115. ARGENTINA MANAGEMENT OF ANTITHROMBIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 116. ARGENTINA MANAGEMENT OF ANTITHROMBIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 117. ARGENTINA MANAGEMENT OF ANTITHROMBIN MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 118. ARGENTINA MANAGEMENT OF ANTITHROMBIN MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 119. ARGENTINA MANAGEMENT OF ANTITHROMBIN MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 120. ARGENTINA MANAGEMENT OF ANTITHROMBIN MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 121. ARGENTINA MANAGEMENT OF ANTITHROMBIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 122. ARGENTINA MANAGEMENT OF ANTITHROMBIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 123. ARGENTINA MANAGEMENT OF ANTITHROMBIN MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 124. ARGENTINA MANAGEMENT OF ANTITHROMBIN MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 125. ARGENTINA MANAGEMENT OF ANTITHROMBIN MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 126. ARGENTINA MANAGEMENT OF ANTITHROMBIN MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 127. EUROPE, MIDDLE EAST & AFRICA MANAGEMENT OF ANTITHROMBIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 128. EUROPE, MIDDLE EAST & AFRICA MANAGEMENT OF ANTITHROMBIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 129. EUROPE, MIDDLE EAST & AFRICA MANAGEMENT OF ANTITHROMBIN MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 130. EUROPE, MIDDLE EAST & AFRICA MANAGEMENT OF ANTITHROMBIN MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 131. EUROPE, MIDDLE EAST & AFRICA MANAGEMENT OF ANTITHROMBIN MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 132. EUROPE, MIDDLE EAST & AFRICA MANAGEMENT OF ANTITHROMBIN MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 133. EUROPE, MIDDLE EAST & AFRICA MANAGEMENT OF ANTITHROMBIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 134. EUROPE, MIDDLE EAST & AFRICA MANAGEMENT OF ANTITHROMBIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 135. EUROPE, MIDDLE EAST & AFRICA MANAGEMENT OF ANTITHROMBIN MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 136. EUROPE, MIDDLE EAST & AFRICA MANAGEMENT OF ANTITHROMBIN MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 137. EUROPE, MIDDLE EAST & AFRICA MANAGEMENT OF ANTITHROMBIN MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 138. EUROPE, MIDDLE EAST & AFRICA MANAGEMENT OF ANTITHROMBIN MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 139. EUROPE, MIDDLE EAST & AFRICA MANAGEMENT OF ANTITHROMBIN MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 140. EUROPE, MIDDLE EAST & AFRICA MANAGEMENT OF ANTITHROMBIN MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 141. UNITED KINGDOM MANAGEMENT OF ANTITHROMBIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 142. UNITED KINGDOM MANAGEMENT OF ANTITHROMBIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 143. UNITED KINGDOM MANAGEMENT OF ANTITHROMBIN MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 144. UNITED KINGDOM MANAGEMENT OF ANTITHROMBIN MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 145. UNITED KINGDOM MANAGEMENT OF ANTITHROMBIN MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 146. UNITED KINGDOM MANAGEMENT OF ANTITHROMBIN MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 147. UNITED KINGDOM MANAGEMENT OF ANTITHROMBIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 148. UNITED KINGDOM MANAGEMENT OF ANTITHROMBIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 149. UNITED KINGDOM MANAGEMENT OF ANTITHROMBIN MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 150. UNITED KINGDOM MANAGEMENT OF ANTITHROMBIN MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 151. UNITED KINGDOM MANAGEMENT OF ANTITHROMBIN MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 152. UNITED KINGDOM MANAGEMENT OF ANTITHROMBIN MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 153. GERMANY MANAGEMENT OF ANTITHROMBIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 154. GERMANY MANAGEMENT OF ANTITHROMBIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 155. GERMANY MANAGEMENT OF ANTITHROMBIN MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 156. GERMANY MANAGEMENT OF ANTITHROMBIN MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 157. GERMANY MANAGEMENT OF ANTITHROMBIN MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 158. GERMANY MANAGEMENT OF ANTITHROMBIN MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 159. GERMANY MANAGEMENT OF ANTITHROMBIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 160. GERMANY MANAGEMENT OF ANTITHROMBIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 161. GERMANY MANAGEMENT OF ANTITHROMBIN MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 162. GERMANY MANAGEMENT OF ANTITHROMBIN MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 163. GERMANY MANAGEMENT OF ANTITHROMBIN MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 164. GERMANY MANAGEMENT OF ANTITHROMBIN MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 165. FRANCE MANAGEMENT OF ANTITHROMBIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 166. FRANCE MANAGEMENT OF ANTITHROMBIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 167. FRANCE MANAGEMENT OF ANTITHROMBIN MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 168. FRANCE MANAGEMENT OF ANTITHROMBIN MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 169. FRANCE MANAGEMENT OF ANTITHROMBIN MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 170. FRANCE MANAGEMENT OF ANTITHROMBIN MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 171. FRANCE MANAGEMENT OF ANTITHROMBIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 172. FRANCE MANAGEMENT OF ANTITHROMBIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 173. FRANCE MANAGEMENT OF ANTITHROMBIN MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 174. FRANCE MANAGEMENT OF ANTITHROMBIN MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 175. FRANCE MANAGEMENT OF ANTITHROMBIN MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 176. FRANCE MANAGEMENT OF ANTITHROMBIN MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 177. RUSSIA MANAGEMENT OF ANTITHROMBIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 178. RUSSIA MANAGEMENT OF ANTITHROMBIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 179. RUSSIA MANAGEMENT OF ANTITHROMBIN MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 180. RUSSIA MANAGEMENT OF ANTITHROMBIN MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 181. RUSSIA MANAGEMENT OF ANTITHROMBIN MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 182. RUSSIA MANAGEMENT OF ANTITHROMBIN MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 183. RUSSIA MANAGEMENT OF ANTITHROMBIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 184. RUSSIA MANAGEMENT OF ANTITHROMBIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 185. RUSSIA MANAGEMENT OF ANTITHROMBIN MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 186. RUSSIA MANAGEMENT OF ANTITHROMBIN MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 187. RUSSIA MANAGEMENT OF ANTITHROMBIN MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 188. RUSSIA MANAGEMENT OF ANTITHROMBIN MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 189. ITALY MANAGEMENT OF ANTITHROMBIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 190. ITALY MANAGEMENT OF ANTITHROMBIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 191. ITALY MANAGEMENT OF ANTITHROMBIN MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 192. ITALY MANAGEMENT OF ANTITHROMBIN MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 193. ITALY MANAGEMENT OF ANTITHROMBIN MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 194. ITALY MANAGEMENT OF ANTITHROMBIN MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 195. ITALY MANAGEMENT OF ANTITHROMBIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 196. ITALY MANAGEMENT OF ANTITHROMBIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 197. ITALY MANAGEMENT OF ANTITHROMBIN MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 198. ITALY MANAGEMENT OF ANTITHROMBIN MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 199. ITALY MANAGEMENT OF ANTITHROMBIN MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 200. ITALY MANAGEMENT OF ANTITHROMBIN MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 201. SPAIN MANAGEMENT OF ANTITHROMBIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 202. SPAIN MANAGEMENT OF ANTITHROMBIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 203. SPAIN MANAGEMENT OF ANTITHROMBIN MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 204. SPAIN MANAGEMENT OF ANTITHROMBIN MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 205. SPAIN MANAGEMENT OF ANTITHROMBIN MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 206. SPAIN MANAGEMENT OF ANTITHROMBIN MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 207. SPAIN MANAGEMENT OF ANTITHROMBIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 208. SPAIN MANAGEMENT OF ANTITHROMBIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 209. SPAIN MANAGEMENT OF ANTITHROMBIN MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 210. SPAIN MANAGEMENT OF ANTITHROMBIN MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 211. SPAIN MANAGEMENT OF ANTITHROMBIN MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 212. SPAIN MANAGEMENT OF ANTITHROMBIN MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 213. UNITED ARAB EMIRATES MANAGEMENT OF ANTITHROMBIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 214. UNITED ARAB EMIRATES MANAGEMENT OF ANTITHROMBIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 215. UNITED ARAB EMIRATES MANAGEMENT OF ANTITHROMBIN MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 216. UNITED ARAB EMIRATES MANAGEMENT OF ANTITHROMBIN MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 217. UNITED ARAB EMIRATES MANAGEMENT OF ANTITHROMBIN MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 218. UNITED ARAB EMIRATES MANAGEMENT OF ANTITHROMBIN MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 219. UNITED ARAB EMIRATES MANAGEMENT OF ANTITHROMBIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 220. UNITED ARAB EMIRATES MANAGEMENT OF ANTITHROMBIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 221. UNITED ARAB EMIRATES MANAGEMENT OF ANTITHROMBIN MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 222. UNITED ARAB EMIRATES MANAGEMENT OF ANTITHROMBIN MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 223. UNITED ARAB EMIRATES MANAGEMENT OF ANTITHROMBIN MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 224. UNITED ARAB EMIRATES MANAGEMENT OF ANTITHROMBIN MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 225. SAUDI ARABIA MANAGEMENT OF ANTITHROMBIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 226. SAUDI ARABIA MANAGEMENT OF ANTITHROMBIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 227. SAUDI ARABIA MANAGEMENT OF ANTITHROMBIN MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 228. SAUDI ARABIA MANAGEMENT OF ANTITHROMBIN MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 229. SAUDI ARABIA MANAGEMENT OF ANTITHROMBIN MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 230. SAUDI ARABIA MANAGEMENT OF ANTITHROMBIN MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 231. SAUDI ARABIA MANAGEMENT OF ANTITHROMBIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 232. SAUDI ARABIA MANAGEMENT OF ANTITHROMBIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 233. SAUDI ARABIA MANAGEMENT OF ANTITHROMBIN MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 234. SAUDI ARABIA MANAGEMENT OF ANTITHROMBIN MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 235. SAUDI ARABIA MANAGEMENT OF ANTITHROMBIN MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 236. SAUDI ARABIA MANAGEMENT OF ANTITHROMBIN MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 237. SOUTH AFRICA MANAGEMENT OF ANTITHROMBIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 238. SOUTH AFRICA MANAGEMENT OF ANTITHROMBIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 239. SOUTH AFRICA MANAGEMENT OF ANTITHROMBIN MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 240. SOUTH AFRICA MANAGEMENT OF ANTITHROMBIN MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 241. SOUTH AFRICA MANAGEMENT OF ANTITHROMBIN MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 242. SOUTH AFRICA MANAGEMENT OF ANTITHROMBIN MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 243. SOUTH AFRICA MANAGEMENT OF ANTITHROMBIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 244. SOUTH AFRICA MANAGEMENT OF ANTITHROMBIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 245. SOUTH AFRICA MANAGEMENT OF ANTITHROMBIN MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 246. SOUTH AFRICA MANAGEMENT OF ANTITHROMBIN MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 247. SOUTH AFRICA MANAGEMENT OF ANTITHROMBIN MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 248. SOUTH AFRICA MANAGEMENT OF ANTITHROMBIN MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 249. DENMARK MANAGEMENT OF ANTITHROMBIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 250. DENMARK MANAGEMENT OF ANTITHROMBIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 251. DENMARK MANAGEMENT OF ANTITHROMBIN MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 252. DENMARK MANAGEMENT OF ANTITHROMBIN MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 253. DENMARK MANAGEMENT OF ANTITHROMBIN MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 254. DENMARK MANAGEMENT OF ANTITHROMBIN MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 255. DENMARK MANAGEMENT OF ANTITHROMBIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 256. DENMARK MANAGEMENT OF ANTITHROMBIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 257. DENMARK MANAGEMENT OF ANTITHROMBIN MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 258. DENMARK MANAGEMENT OF ANTITHROMBIN MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 259. DENMARK MANAGEMENT OF ANTITHROMBIN MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 260. DENMARK MANAGEMENT OF ANTITHROMBIN MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 261. NETHERLANDS MANAGEMENT OF ANTITHROMBIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 262. NETHERLANDS MANAGEMENT OF ANTITHROMBIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 263. NETHERLANDS MANAGEMENT OF ANTITHROMBIN MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 264. NETHERLANDS MANAGEMENT OF ANTITHROMBIN MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 265. NETHERLANDS MANAGEMENT OF ANTITHROMBIN MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 266. NETHERLANDS MANAGEMENT OF ANTITHROMBIN MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 267. NETHERLANDS MANAGEMENT OF ANTITHROMBIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 268. NETHERLANDS MANAGEMENT OF ANTITHROMBIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 269. NETHERLANDS MANAGEMENT OF ANTITHROMBIN MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 270. NETHERLANDS MANAGEMENT OF ANTITHROMBIN MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 271. NETHERLANDS MANAGEMENT OF ANTITHROMBIN MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 272. NETHERLANDS MANAGEMENT OF ANTITHROMBIN MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 273. QATAR MANAGEMENT OF ANTITHROMBIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 274. QATAR MANAGEMENT OF ANTITHROMBIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 275. QATAR MANAGEMENT OF ANTITHROMBIN MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 276. QATAR MANAGEMENT OF ANTITHROMBIN MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 277. QATAR MANAGEMENT OF ANTITHROMBIN MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 278. QATAR MANAGEMENT OF ANTITHROMBIN MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 279. QATAR MANAGEMENT OF ANTITHROMBIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 280. QATAR MANAGEMENT OF ANTITHROMBIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 281. QATAR MANAGEMENT OF ANTITHROMBIN MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 282. QATAR MANAGEMENT OF ANTITHROMBIN MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 283. QATAR MANAGEMENT OF ANTITHROMBIN MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 284. QATAR MANAGEMENT OF ANTITHROMBIN MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 285. FINLAND MANAGEMENT OF ANTITHROMBIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 286. FINLAND MANAGEMENT OF ANTITHROMBIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 287. FINLAND MANAGEMENT OF ANTITHROMBIN MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 288. FINLAND MANAGEMENT OF ANTITHROMBIN MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 289. FINLAND MANAGEMENT OF ANTITHROMBIN MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 290. FINLAND MANAGEMENT OF ANTITHROMBIN MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 291. FINLAND MANAGEMENT OF ANTITHROMBIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 292. FINLAND MANAGEMENT OF ANTITHROMBIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 293. FINLAND MANAGEMENT OF ANTITHROMBIN MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 294. FINLAND MANAGEMENT OF ANTITHROMBIN MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 295. FINLAND MANAGEMENT OF ANTITHROMBIN MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 296. FINLAND MANAGEMENT OF ANTITHROMBIN MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 297. SWEDEN MANAGEMENT OF ANTITHROMBIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 298. SWEDEN MANAGEMENT OF ANTITHROMBIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 299. SWEDEN MANAGEMENT OF ANTITHROMBIN MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 300. SWEDEN MANAGEMENT OF ANTITHROMBIN MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 301. SWEDEN MANAGEMENT OF ANTITHROMBIN MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 302. SWEDEN MANAGEMENT OF ANTITHROMBIN MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 303. SWEDEN MANAGEMENT OF ANTITHROMBIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 304. SWEDEN MANAGEMENT OF ANTITHROMBIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 305. SWEDEN MANAGEMENT OF ANTITHROMBIN MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 306. SWEDEN MANAGEMENT OF ANTITHROMBIN MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 307. SWEDEN MANAGEMENT OF ANTITHROMBIN MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 308. SWEDEN MANAGEMENT OF ANTITHROMBIN MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 309. NIGERIA MANAGEMENT OF ANTITHROMBIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 310. NIGERIA MANAGEMENT OF ANTITHROMBIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 311. NIGERIA MANAGEMENT OF ANTITHROMBIN MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 312. NIGERIA MANAGEMENT OF ANTITHROMBIN MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 313. NIGERIA MANAGEMENT OF ANTITHROMBIN MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 314. NIGERIA MANAGEMENT OF ANTITHROMBIN MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 315. NIGERIA MANAGEMENT OF ANTITHROMBIN MARKET SIZE, BY DISTR

Samples

LOADING...

Companies Mentioned

The companies profiled in this Management of Antithrombin Market report include:

CSL Limited
Grifols, S.A.
Octapharma AG
Kedrion Biopharma S.p.A.
LFB Group
Baxter International Inc.
Biotest AG
Sanquin Blood Supply Foundation
Green Cross Corporation
Bio Products Laboratory Ltd

License	Properties	Price
SINGLE USER LICENSE PDF, Excel and Online Access	This is a single user license, allowing one user access to the product.	€3144EUR$3,545USD£2,727GBP €3494EUR$3,939USD£3,030GBP
1 - 5 USER LICENSE PDF, Excel and Online Access	This is a 1-5 user license, allowing up to five users have access to the product.	€3392EUR$3,824USD£2,942GBP €3769EUR$4,249USD£3,269GBP
SITE LICENSE PDF, Excel and Online Access	This is a site license, allowing all users within a given geographical location of your organization access to the product.	€4597EUR$5,183USD£3,987GBP €5108EUR$5,759USD£4,430GBP
ENTERPRISE LICENSE PDF, Excel and Online Access	This is an enterprise license, allowing all employees within your organization access to the product.	€5563EUR$6,272USD£4,825GBP €6181EUR$6,969USD£5,361GBP

Antithrombin Market Snapshot

Scope & Segmentation of the Antithrombin Market

Key Takeaways for Decision-Makers

Tariff Impact: Navigating U.S. Trade Policy Shifts

Antithrombin Market Methodology & Data Sources

Why This Report Matters

Conclusion: Integrated Strategies for Future-Ready Antithrombin Management

Table of Contents

Samples

Companies Mentioned

Related Topics

Related Reports

Antithrombin Market - Global Forecast 2025-2030

Antithrombin - Global Strategic Business Report

Antithrombin Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

2024-2028 Global Antithrombin II Testing in 90 Countries: Five-Year Volume and Sales Forecasts, Supplier Sales and Shares, Competitive Analysis, Diagnostic Assays and Instrumentation

2025 Global Forecast for Antithrombin Market (2026-2031 Outlook)-High Tech Outlook Report